Nateglinide D5
| Product Name | Nateglinide D5 |
|---|---|
| Alternate Names | Nateglinide Stable Isotopes, Stable Isotopes of Nateglinide |
| CAT No. | CS-O-06803 |
| CAS No. | 1227666-13-8 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 322.5 g/mol |
| Mol. For. | C19H22D5NO3 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Nateglinide |
| Purity | 98.95 |
| Therapeutic | Anti-Diabetic |
| Smileys | O=C([C@@H]1CC[C@@H](C(C)C)CC1)N[C@@H](C(O)=O)CC(C([2H])=C2[2H])=C(C([2H])=C2[2H])[2H] |
| Canonical Smiles | CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O |
| InchIKey | OELFLUMRDSZNSF-ZBRYERADSA-N |
| Inchl | InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1/i3D,4D,5D,6D,7D |
| IUPAC | (2R)-3-(2,3,4,5,6-pentadeuteriophenyl)-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Nateglinide D5 is a deuterium-labeled version of Nateglinide, a medication used in the management of type 2 diabetes. As a type of oral hypoglycemic agent, Nateglinide works by stimulating the release of insulin from the pancreas in response to a meal. This helps to control blood sugar levels in individuals with type 2 diabetes, a condition in which the body is unable to effectively use insulin to regulate glucose.
The chemical formula of Nateglinide D5 is C19H19D5N2O3S, and its molecular weight is 337.51 g/mol. Its chemical structure is similar to that of Nateglinide, but with five deuterium atoms incorporated into the molecule.
Nateglinide D5 is primarily used in pharmacokinetic and bioavailability studies to determine the fate of Nateglinide in the body. Deuterium labeling allows for the differentiation between the labeled drug and endogenous compounds or metabolites, improving the accuracy of the analysis.
Overall, Nateglinide D5 is a useful tool in diabetes research that helps to better understand the pharmacokinetics and efficacy of Nateglinide as a treatment for type 2 diabetes.
Get an Instant Quote
Related Compounds
D-Phenylalanyl-d5 Nateglinide | Nateglinide-d5 Ethyl Ester |